Search

everythinglearnresearchcommunity

for

Search:↓

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Most cases of Temporal Triangular Alopecia are found in early childhood and may be related to genetic conditions.

Trichoscopy helps accurately diagnose temporal triangular alopecia.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Trichothiodystrophy is a rare genetic disorder causing hair issues and sometimes linked to DNA repair defects.

TQC shows promise for better hair regrowth in treating hair loss.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Temporal triangular alopecia is a non-scarring hair loss seen in some Asian children.

The combination therapy was effective and well-tolerated, especially in young patients.

A 23-year-old man has a benign, non-progressive hair loss patch that doesn't respond to treatment but can be cosmetically treated.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Trichoscopy effectively diagnoses temporal triangular alopecia in children.

HS needs personalized treatment plans and more research.

HAC and BAC improve skin targeting and reduce diffusion without causing irritation.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Triangular temporal alopecia can occur in adults and should be correctly identified to prevent misdiagnosis.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

The program increased awareness of traction alopecia but didn't significantly change hairstyling habits.